Orphanin FQ/Nociceptin receptor binding studies

被引:18
作者
Dooley, CT [1 ]
Houghten, RA [1 ]
机构
[1] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA
关键词
D O I
10.1016/S0196-9781(00)00231-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A review of the binding studies performed on the receptor (ORL) for Orphanin FQ/Nociceptin is presented. Binding studies have been conducted using a variety of receptor sources: cell lines expressing the cloned receptor, cell lines endogenously expressing the receptor, and brain and other tissue from several different species. Binding studies of opioids, new ligands and antagonists at the ORL receptor are briefly discussed. Saturation, competition and binding kinetic experiments, and the effects of buffer composition are reviewed. There are numerous instances of conflicting data in published reports on OFQ; the basis for these disparities is as yet undetermined. This review endeavors to compile the results and conditions employed in binding studies as an aid to current and new researchers in this field. In an attempt to explain binding disparities, we have determined that Orphanin/Nociceptin binds to glass fiber filtermats in a "specific" manner; these new data are presented. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:949 / 960
页数:12
相关论文
共 64 条
[1]   Relationship between binding affinity and functional activity of nociceptin/orphanin FQ [J].
Adapa, ID ;
Toll, L .
NEUROPEPTIDES, 1997, 31 (05) :403-408
[2]  
Albrecht E, 1998, J PHARMACOL EXP THER, V286, P896
[3]   Interaction of [H-3]orphanin FQ and I-125-Tyr14-orphanin FQ with the orphanin FQ receptor: Kinetics and modulation by cations and guanine nucleotides [J].
Ardati, A ;
Henningsen, RA ;
Higelin, J ;
Reinscheid, RK ;
Civelli, O ;
Monsma, FJ .
MOLECULAR PHARMACOLOGY, 1997, 51 (05) :816-824
[4]   The stereoselective κ-opioid receptor antagonist Mr2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor [J].
Bauer, U ;
Nakazi, M ;
Kathmann, M ;
Göthert, M ;
Schlicker, E .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (01) :17-20
[5]   Ligands for κ-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library [J].
Becker, JAJ ;
Wallace, A ;
Garzon, A ;
Ingallinella, P ;
Bianchi, E ;
Cortese, R ;
Simonin, F ;
Kieffer, BL ;
Pessi, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) :27513-27522
[6]   Nociceptin binding sites in frog (Rana esculenta) brain membranes [J].
Benyhe, S ;
Menory, K ;
Farkas, J ;
Tóth, G ;
Guerrini, R ;
Salvadori, S ;
Orosz, G ;
Wollemann, M ;
Borsodi, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (03) :592-596
[7]   Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin orphanin FQ [J].
Berger, H ;
Albrecht, E ;
Wallukat, G ;
Bienert, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (03) :555-558
[8]   Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies [J].
Bigoni, R ;
Giuliani, S ;
Calo, G ;
Rizzi, A ;
Guerrini, R ;
Salvadori, S ;
Regoli, D ;
Maggi, CA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (03) :160-167
[9]   MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A PUTATIVE MEMBER OF THE RAT OPIOID RECEPTOR GENE FAMILY THAT IS NOT A MU-OPIOID, DELTA-OPIOID OR KAPPA-OPIOID RECEPTOR-TYPE [J].
BUNZOW, JR ;
SAEZ, C ;
MORTRUD, M ;
BOUVIER, C ;
WILLIAMS, JT ;
LOW, M ;
GRANDY, DK .
FEBS LETTERS, 1994, 347 (2-3) :284-288
[10]   Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids [J].
Butour, JL ;
Moisand, C ;
Mazarguil, H ;
Mollereau, C ;
Meunier, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 321 (01) :97-103